The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.

Afon Technology has been a leader in diabetes innovation with its GlucowearTM device, the world’s first non-invasive glucose ...

Scientists have identified a simple, noninvasive method for assessing blood glucose regulation using continuous glucose monitoring (CGM) data. Their approach, which tracks glucose fluctuations, ...

Biolinq received $100 million in a Series C funding round to bring its wearable for patients with diabetes to market, the ...

Biolinq has raised $100 million in venture capital financing to help complete the development of its wearable glucose ...

The highs and lows of blood glucose aren't just an energy rollercoaster; they could be a key to detecting diabetes risk early and spare you a needle prick or two.

Glucose Sensor MarketThe global glucose sensor market is projected to witness substantial growth, reaching a valuation of USD 20,421.4 million by 2034, according to a recent report. The market, ...

A leading Welsh innovator in healthcare technology is celebrating once again after its innovative non-invasive blood glucose ...

The global biosensors market is set for substantial growth, with a projected increase in market value from US$ 32.14 billion in 2024 to US$ 75.84 billion by 2033, reflecting a compound annual growth ...

Northeastern University Entrepreneurs Club, or NUEC, hosted its annual Demo Day April 1 through its flagship program Husky ...